共查询到20条相似文献,搜索用时 15 毫秒
1.
Abdellah El Maghraoui Ahmed Anas Guerboub Lahsen Achemlal Aziza Mounach Abderrazak Nouijai Mirieme Ghazi Ahmed Bezza Mohamed Adnane Tazi 《Journal of clinical densitometry》2006,9(4):87
Bone mineral density (BMD) measurements using dual-energy X-ray absorptiometry (DXA) are widely used to diagnose osteoporosis and assess its severity. Previous studies show the necessity to establish reference data for bone mass measurements for each particular population. Such data are lacking for the Moroccan population. The aim of this study was to determine spine and femur BMD reference values for the Moroccan female population and to compare them with values from western and other Arab countries. A cross-sectional study of 569 Moroccan women, (randomly selected in the area of Rabat, the capital of Morocco, aged between 20 and 79 yr) was carried out to establish reference values of BMD. Measurements were taken at the lumbar spine and proximal femurs using DXA (Lunar Prodigy Vision, GE). The data were compared with published normative data taken by United States (U.S.), European, Kuwaiti, Lebanese, and Saudi women over 6 decades of age. The percentage of osteoporosis in postmenopausal women using our reference curve was compared to that observed when the other curves (US, European and Arab) implemented in the Lunar machine was used. Our results showed that the Moroccan women showed the expected decline in BMD at both sites with age after peaking at 20–29 years of age. Moroccan females have lower BMD at the spine than U.S., Europeans, and Kuwaitis (approximately 10–12% for patients older than 50 yr). The BMD values of the total femur in Moroccan females were close to western (European and American), and Kuwaitis, but higher than Lebanese and Saudis. Using our reference database, 37.9% of postmenopausal women had spine osteoporosis vs. 39.6% and 23.4% using US/European and Arabic Lunar reference values respectively. At the femurs, 6.7% had osteoporosis vs. 2.5% using the Arabic Lunar reference values. In conclusion, our study emphasizes the importance of using population-specific reference values for BMD measurements to avoid over or underdiagnosis of osteoporosis. 相似文献
2.
软化型氟骨症大鼠骨密度和骨生物力学的变化及硼预防的影响 总被引:4,自引:0,他引:4
目的:观察及分析软化型氟症大鼠骨密度(BMD)和骨生物力学特性的变化及硼预防对此的影响。方法:SD大鼠分为对照组、低过量氟组、高过量氟组和硼预防组,实验20周后测量大鼠BMD和血清氟、硼含量、四肢骨氟含量及进行股骨生物力学检测。结果:低过量氟组和高过量氟组大鼠血清游离氟、骨氟含量显著增高;全身和胫骨BMD降低,腰椎BMD变化不大;股骨最大负荷减低,最大形变增加。相比高过量氟组,硼预防组大鼠血清游离氟和骨氟含量明显下降;全身、腰椎和胫骨BMD显著增高;胫骨最大负荷明显增加,最大形变明显减小。4组大鼠血清硼含量无显著性差异。结论:软化型氟骨症大鼠骨密度和骨生物力学特性变化明显,呈现骨软化和骨质疏松;饲料加硼对此变化有一定的预防作用。 相似文献
3.
Bone Mineral Density of the Lumbar Spine is Associated with TNF Gene Polymorphisms in Early Postmenopausal Japanese Women 总被引:5,自引:0,他引:5
Furuta I Kobayashi N Fujino T Kobamatsu Y Shirogane T Yaegashi M Sakuragi N Cho K Yamada H Okuyama K Minakami H 《Calcified tissue international》2004,74(6):509-515
We investigated the relationships between tumor necrosis factor (TNF) gene polymorphism, circulating TNF-alpha (TNF-) concentrations, and bone mineral density (BMD) in the lumbar spine. TNF gene polymorphisms studied were the Nco I polymorphism within the first intron of TNF-beta (TNF-) and three single nucleotide polymorphisms in the promoter region of the TNF- gene, at positions –857, –863, and –1031. Allelic variants of the TNF gene were identified using restriction fragment length polymorphism (RFLP) analysis in 177 postmenopausal Japanese women within 10 years after menopause, aged 56.4 ± 4.5 years (mean ± SD). A significantly higher prevalence of the alleles TNF--863A (20.3% versus 9.9%) and TNF--1031C (21.3% versus 12.4%) was seen in the low BMD group (Z-score < 0, n = 91) than in the high BMD group (0 Z-score, n = 86). In genotype analysis, although difference did not reach a significant level, women with the rarest allelic variants, i.e., homozygous TNFb1, TNF--863A, and TNF--1031C, showed the lowest BMD Z-scores. Women with another rarest allelic variant, TNF--857T/T had significantly lower BMD Z-scores than did women with TNF--857C/T or –857C/C. The BMD Z-score decreased significantly with an increase in the total number of such rare alleles. Serum concentrations of TNF- did not differ significantly among groups divided by genotypes. Multiple linear regression analysis revealed that the total number of rare alleles, in addition to the body mass index and the number of years since menopause, was an independent predictor of the BMD. These presumptive functional polymorphisms of the TNF gene may be associated with the lumbar spine BMD in early postmenopausal Japanese women. 相似文献
4.
Adami S Gatti D Bertoldo F Sartori L Di Munno O Filipponi P Marcocci C Frediani B Palummeri E Fiore CE Costi D Rossini M 《Calcified tissue international》2008,83(5):301-307
Compliance to osteoporosis treatment with oral bisphosphonates is very poor. Intermittent intravenous bisphosphonate is a
useful alternative, but this route is not readily available. Neridronate, a nitrogen-containing bisphosphonate that can be
given intramuscularly (IM), was tested in a phase 2 clinical trial in 188 postmenopausal osteoporotic women randomized to
IM treatment with 25 mg neridronate every 2 weeks, neridronate 12.5 or 25 mg every 4 weeks, or placebo. All patients received
calcium and vitamin D supplements. The patients were treated over 12 months with 2-year posttreatment follow-up. After 12-month
treatment, all three doses were associated with significant bone mineral density (BMD) increases at both the total hip and
spine. A significant dose–response relationship over the three doses was observed for the BMD changes at the total hip but
not at the spine. Bone alkaline phosphatase decreased significantly by 40–55% in neridronate-treated patients, with an insignificant
dose–response relationship. Serum type I collagen C-telopeptide decreased by 58–79%, with a significant dose–response relationship
(P < 0.05). Two years after treatment discontinuation, BMD declined by 1–2% in each dose group, with values still significantly
higher than baseline at both the spine and the total hip. Bone turnover markers progressively increased after treatment discontinuation,
and on the second year of follow-up the values were significantly higher than pretreatment baseline. The results of this study
indicate that IM neridronate might be of value for patients intolerant to oral bisphosphonates and unwilling or unable to
undergo intravenous infusion of bisphosphonates. 相似文献
5.
6.
We studied the relationships between weight variables and spine bone mineral density (BMD) in 183 postmenopausal women aged
34–76 years. There was a significant positive correlation of current body mass index (cBMI) and % of ideal body weight (IBW)
with BMD. Moreover, the increase in BMI and % IBW was also positively and significantly associated with a higher age-adjusted
lumbar BMD. Weight gain, estimated as the difference between current body weight and past ``ideal' body weight, was associated
with significant age-adjusted BMD with a threshold of 17%, and postmenopausal women with a gain of over 17% had significantly
higher spine BMD.
Received: 21 October 1997 / Accepted: 6 October 1998 相似文献
7.
J.-F. Chiu S.-J. Lan C.-Y. Yang P.-W. Wang W.-J. Yao I.-H. Su C.-C. Hsieh 《Calcified tissue international》1997,60(3):245-249
This study examined bone density among postmenopausal Buddhist nuns and female religious followers of Buddhism in southern
Taiwan and related the measurements to subject characteristics including age, body mass, physical activity, nutrient intake,
and vegetarian practice. A total of 258 postmenopausal Taiwanese vegetarian women participated in the study. Lumbar spine
and femoral neck bone mineral density (BMD) were measured using dual-photon absorptimetry. BMD measurements were analyzed
first as quantitative outcomes in multiple regression analyses and next as indicators of osteopenia status in logistic regression
analyses. Among the independent variables examined, age inversely and body mass index positively correlated with both the
spine and femoral neck BMD measurements. They were also significant predictors of the osteopenia status. Energy intake from
protein was a significant correlate of lumbar spine BMD only. Other nutrients, including calcium and energy intake from nonprotein
sources, did not correlate significantly with the two bone density parameters. Long-term practitioners of vegan vegetarian
were found to be at a higher risk of exceeding lumbar spine fracture threshold (adjusted odds ratio = 2.48, 95% confidence
interval = 1.03–5.96) and of being classified as having osteopenia of the femoral neck (3.94, 1.21–12.82). Identification
of effective nutrition supplements may be necessary to improve BMD levels and to reduce the risk of osteoporosis among long-term
female vegetarians.
Received: 10 May 1996 / Accepted: 9 August 1996 相似文献
8.
Rim Cherif Feten Mahjoub Hela Sahli Elhem Cheour Laurence Vico Mohsen Sakly Nebil Attia 《Journal of clinical densitometry》2018,21(2):163-171
The association of bone mineral density (BMD) with obesity and insulin resistance remains unclear. This study aimed to explore these associations in Tunisian menopausal women. Eighty-one postmenopausal women were recruited. Data were analyzed for obese (N?=?57) and non-obese women (N?=?24) and for insulin-resistant (N?=?43) and non insulin-resistant women (N?=?36). Anthropometric and biochemical parameters were recorded. BMD in different sites and body composition were measured using dual-energy X-ray absorptiometry. Higher BMD was observed in obese women than those non-obese in the left femur (p?=?0.0067), right femur (p?=?0.0108), total hip (p?=?0.0077), and the whole body (p?=?0.0276). Also BMD was significantly greater in insulin-resistant women than in non–insulin-resistant women when measured in the left femur and total hip. Positive correlations were recorded between BMD and anthropometric parameters, body composition parameters, and glycemia (r?=?0.249, p?<?0.05). Multiple linear regression analysis shows that only trunk fat (p?<?0.05) and lean mass (p?<?0.05) were independently and positively related to BMD, and the waist circumference was the only anthropometric parameter independently and negatively associated to BMD. BMD is improved in obese and insulin-resistant women. Also, trunk fat and lean mass are likely to be key positive independent factors for BMD. 相似文献
9.
闫德文 《中国骨质疏松杂志》1997,3(1):48-50
本文采用了高精度的双能X线骨密度仪和—一配对(包括年龄-性别-体重指数相匹配)的方法对15例新诊断的糖尿病病人和15例非糖尿病健康者腰椎(L2~4)和左股骨近端骨密度进行了检测,发现糖尿病患者中轴骨骨密度明显降低(P<0.05~0.001),腰椎和股骨近端骨量丢失率分别为9.26%和10.89%。同时对其骨密度的变化与性别、年龄的关系进行了分析。值得注意是非老年(<55岁)糖尿病组中轴骨骨密度比老年组更广泛更显著地低于对照组,似乎提示老年糖尿病患者骨量丢失速率减慢,且非老年糖尿病骨丢失以椎体附件和股骨为主。 相似文献
10.
N. B. Watts D. K. Jenkins J. M. Visor D. C. Casal P. Geusens 《Osteoporosis international》2001,12(4):279-288
Alendronate therapy in osteoporotic women decreases bone turnover and increases bone mineral density (BMD). Optimal patient
management should include verification that each patient is responding to therapy. Markers of bone turnover and BMD have both
been proposed for this purpose. We have investigated changes resulting from alendronate therapy with an enzyme immunoassay
for bone alkaline phosphatase (BAP) and compared it with total alkaline phosphatase (TAP) and BMD of the lumbar spine, hip,
and total body. Subjects were drawn from a multicenter randomized, placebo-controlled trial of alendronate in postmenopausal
women with osteoporosis. BAP and TAP levels were measured at baseline and following 3, 6 and 12 months of therapy with either
placebo (n= 180) or alendronate 10 mg/day (n= 134). All subjects also received 500 mg/day supplemental calcium. BMD was measured at baseline and following 3, 6, 12, 18,
24 and 36 months of therapy. To compare BAP, TAP and BMD at each site for identifying women that experienced a skeletal effect
of alendronate, we calculated least significant change (LSC) values from the long-term intraindividual variability in each
placebo-treated woman. Median levels of BAP decreased by 34%, 44% and 43% at 3, 6 and 12 months, respectively, in alendronate-treated
women (p<0.0001 compared with baseline and with placebo). These changes were significantly greater (p<0.0001) than changes observed for TAP. Following 6 months of alendronate therapy, 90% of the women had experienced a decrease
in BAP exceeding the LSC compared with only 71% for TAP. The greatest number of women similarly identified with BMD at any
site (i.e. a gain in BMD exceeding the LSC) was 81% for spinal BMD at 36 months. All other sites were less than 70% at 36
months. Short-term changes in BAP and TAP were modestly associated with subsequent changes in BMD at all sites (Spearman’s
rho −0.22 to −0.52, p<0.05). Compared with TAP and BMD, BAP testing rapidly and sensitively identified skeletal effects of alendronate thus enabling
appropriate drug monitoring of osteoporotic women. Though BAP and TAP changes were modestly predictive of BMD changes, the
value of the bone marker tests is their ability to detect rapidly a skeletal effect of therapy.
Received: 19 May 2000 / Accepted: 31 October 2000 相似文献
11.
Colles' fracture has been shown to be associated with an increased risk of hip fracture. The incidence of low bone mineral
density (BMD) and high bone turnover in such patients is uncertain. The aim of this study was to prospectively assess BMD
and bone turnover in a cohort of consecutive postmenopausal Colles' fracture patients. BMD (spine, hip and contra-lateral
radius) was measured by dual-energy X-ray absorptiometry (DXA) within 2 weeks of fracture. Bone turnover was assessed within
4 days by measurement of serum osteocalcin, total alkaline phosphatase (TALP), bone-specific alkaline phosphatase (BSAP) and
urine hydroxyproline. We recruited 106 (71%) of 149 consecutive patients. Fifty-one per cent of subjects had a history of
previous fracture, and 25% a past history of wrist, hip or vertebral body fracture. The incidence of osteoporosis was 21%,
42% and 22% at the spine, hip and radius respectively. Fifty per cent of subjects had osteoporosis of at least one of these
sites. When compared with the values expected for their age the patients were found to have higher BMD than expected at the
spine, and slightly lower BMD at the hip and distal radius. Patients aged 65 years or less had lower hip BMD than expected
from the age-matched normal range (p < 0.01). Osteocalcin and TALP levels did not differ from the normal ranges, but BSAP and hydroxyproline levels were significantly
elevated (p < 0.001), within 37% and 25% of patients having levels above the respective normal ranges. We conclude that osteoporosis
is common in patients with Colles' fracture; however, in older patients BMD is not lower than would be expected in the normal
population. In patients aged 65 years or less BMD is lower than expected at the hip. Bone turnover rate is high in many such
patients. Intervention to prevent future fracture would be appropriate in women aged 65 years or less with Colles' fracture. 相似文献
12.
Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal Women 总被引:8,自引:0,他引:8
Choi JY Shin A Park SK Chung HW Cho SI Shin CS Kim H Lee KM Lee KH Kang C Cho DY Kang D 《Calcified tissue international》2005,77(3):152-159
To evaluate the effects of genetic polymorphisms of OPG, RANK, and ESR1, which regulate osteoclastogenesis, on bone mineral density (BMD), a cross-sectional study was conducted in 650 Korean postmenopausal
women. BMDs of the distal radius and the calcaneus were measured by dual energy X-ray absorptiometry (DXA). Genetic polymorphisms
of OPG 163 A > G, 1181 G > C; RANK 421 C > T, 575 T > C; and ESR1 1335 C > T, 2142 G > A were determined by matrix-assisted laser desorption/ionization—time of flight (MALDI-ToF) mass spectrometry.
The differences between the BMDs of the genotypes of OPG, RANK, and ESR1 were analyzed by multiple linear regression model adjusted for age and body mass index. Women with the OPG 1181 CC genotype had higher BMDs at the distal radius (7%) and calcaneus (10%) than those with the GG genotype; and these
differences were statistically significant (P = 0.001 and P = 0.007, respectively). A significant association was also observed between RANK 575 T > C and calcaneus BMD (P for trend = 0.017). No significant association was observed between BMDs and the polymorphisms of ESR1. The association between OPG 1181 G > C and BMD was profound in subjects with the RANK 575 TT or ESR1 2142 GG genotypes; women with OPG 1181 CC had higher BMDs at the distal radius (11%) and calcaneus (11%) than those with OPG 1181 GG only in women with RANK 575 TT genotype (P = 0.002 and P = 0.021, respectively). These results suggest that OPG genetic polymorphisms, especially with the RANK 575 TT or ESR1 2142 GG genotypes, are related to low BMD in postmenopausal Korean women. 相似文献
13.
Bone Mineral Density and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women 总被引:2,自引:0,他引:2
De Leo V Ditto A la Marca A Lanzetta D Massafra C Morgante G 《Calcified tissue international》2000,66(4):263-267
Bone mineral density (BMD) measured by densitometry is the elective parameter for the diagnosis of osteopenia and osteoporosis.
Biochemical markers have been proposed as sensitive indicators of high bone turnover and for monitoring response to antiresorptive
treatment. We conducted a retrospective study to investigate the values of biochemical markers of bone metabolism with a view
to early diagnosis of osteoporosis and monitoring of hormone replacement and calcitonin therapy. The subjects were 415 women,
mean age 51 ± 8 years (43–62 years) in peri- and postmenopause, recruited at the Menopause Center of Obstetrics and Gynecology
Department of Siena University and divided in five groups. Bone densitometry was performed in all subjects and blood samples
were taken for assayed biochemical markers, that is, [osteocalcin (OC), parathyroid hormone (PTH), type 1 procollagen (PICP),
and calcitonin (CT)].
Three groups of women were divided into two subgroups: those with normal and those with low BMD (<1 SD). Basal concentrations
of PCP1, OC, PTH, and CT were compared in the various groups. Two groups of postmenopausal women with BMD below the normal
were treated with estrogen replacement therapy and unmodified eel calcitonin.
We evaluated whether some of these biochemical markers of bone turnover could help identify women with low BMD and whether
they could be useful for monitoring the results of antiresorptive therapies.
Markers of bone formation (PICP and OC) make it possible to distinguish women with high turnover who are at risk for osteoporosis
from women with low turnover in menopause. A good correlation was also found between changes in levels of these markers and
changes in BMD during treatments, which suggests that the PICP and OC would be useful for monitoring response to antiresorptive
therapy.
Received: 29 March 1998 / Accepted: 2 November 1999 相似文献
14.
15.
Hormone replacement therapy (HRT) prevents bone loss in postmenopausal women. Up to 20% of women demonstrate no increase
in bone mineral density (BMD) on HRT. We examined whether early changes in serum bone alkaline phosphatase (B-ALP) predict
long-term BMD changes in postmenopausal women on HRT. Ninety women within 1 year of menopause were randomly assigned to continuous
or sequential estrogen/progestin (beta estradiol/norethisterone acetate) if naturally postmenopausal, or beta estradiol if
within 1 month of surgical menopause. Spine, femoral neck BMD (DXA), and B-ALP were determined over 2 years. The mean percent
BMD changes were 3.8%, 2.9%, 1.6% in the spine and 2.4%, 4.0%, 1.1% in the femoral neck in sequential, continuous, and estrogen
alone treatment groups, respectively, significantly different from zero except for femoral neck BMD change in the estrogen
alone group. HRT was associated with spine and femoral neck BMD loss in 17.4% and 25.3% of women, respectively. In estrogen/progestin-treated
women, baseline B-ALP correlated with spine BMD change (r = 0.42, P < 0.01). At 3 months, B-ALP dropped significantly in the estrogen/progestin-groups with a maximal decrease at 12 months,
but no change from baseline in the estrogen alone group. Using quartile analysis, women with the greatest drop in B-ALP (≥50%)
at 6 months demonstrated the greatest gain in spine BMD at 2 years. A 40% decrease at 6 months in B-ALP had a 56% sensitivity,
83% specificity, 95% positive predictive value for spine BMD gain at 2 years. The decrease in B-ALP can be used to monitor
BMD response to HRT.
Received: 6 January 1999 / Accepted: 13 August 1999 相似文献
16.
Lumachi F Ermani M Basso SM Camozzi V Nardi A Favia G Luisetto G 《Calcified tissue international》2003,73(1):44-48
The aims of this study were (1) to analyze whether correlations exist between lumbar spine (LS) bone mineral density (BMD) and the main preoperative biochemical parameters in a large population of patients with primary hyperparathyroidism (HPT); and (2) to evaluate the LS-BMD changes after parathyroidectomy (PTx) at long-term follow-up. Sixty-two patients (median age 57 years, range 23–82 years) with confirmed primary HPT underwent LS osteodensitometry by dual-energy X-ray absorptiometry with BMD measurements at the L2–L4 region before surgery and at 1 year and 2 years after successful PTx. Three groups of patients were considered: Group A (men, n = 14, 22.6%), Group B (premenopausal women, n = 12, 19.3%), and Group C (postmenopausal women, n = 36, 58.1%). There were no linear correlations (P = NS) among the main biochemical parameters, the age of the patients, and their baseline LS-BMD values that were significantly (P < 0.01) lower in Group C patients. At 2-year follow-up the LS-BMD improved by 13.0%, 11.5%, and 11.7% in Groups A, B, and C, respectively (P = NS). In order to compare groups with the same linear relationship between age and LS-BMD, a subgroup of postmenopausal patients aged 60 years (Group C2) was considered. ANOVA showed that the improvement of the LS-BMD at l- and 2-year follow-up was higher (P = 0.002) in Group B than in Group C2 patients. The result was confirmed by using the Mann-Whitney U-test (P = 0.0078). Improvement of LS-BMD after successful PTx was significantly (P < 0.01) higher in premenopausal women, suggesting a possible role of estrogen hormone in complete bone remodeling.
This study was presented at the XXVII European Symposium on Calcified Tissue, Tampere, Finland, 6–19 May, 2000 相似文献
17.
Fratzl P Roschger P Fratzl-Zelman N Paschalis EP Phipps R Klaushofer K 《Calcified tissue international》2007,81(2):73-80
Risedronate is used in osteoporosis treatment. Postmenopausal women enrolled in the Vertebral Efficacy with Risedronate Therapy
trial received either risedronate (5 mg/day) or placebo for 3 years. Subjects received calcium and vitamin D supplementation
if deficient at baseline. Lumbar spine bone mineral density (BMD) was measured at baseline and at 3 years. Quantitative back-scattered
electron imaging (qBEI) was performed on paired iliac crest biopsies (risedronate, n = 18; placebo, n = 13) before and after treatment, and the mineral volume fraction in the trabecular bone was calculated. Combining dual-energy
X-ray absorptiometric values with the mineral volume fraction for the same patients allowed us to calculate the relative change
in trabecular bone volume with treatment. This showed that the effect on BMD was likely to be due partly to changes in matrix
mineralization and partly due to changes in bone volume. After treatment, trabecular bone volume in the lumbar spine tended
to increase in the risedronate group (+2.4%, nonsignificant) but there was a significant decrease (−3.7%, P < 0.05) in the placebo group. Calcium supplementation with adequate levels of vitamin D led to an ∼3.3% increase in mineral
content in the bone material independently of risedronate treatment. This increase was larger in patients with lower matrix
mineralization at baseline and likely resulted from correction of calcium/vitamin D deficiency as well as from reduced bone
remodeling. Combining BMD and bone mineralization density distribution data show that in postmenopausal osteoporosis 3-year
treatment with risedronate preserves or may increase trabecular bone volume, unlike placebo. This analysis also allows, for
the first time, separation of the contributions of bone volume and matrix mineralization to the increase in BMD. 相似文献
18.
Leticia S. Souza Neuza Felix Rochette Diego França Pedrosa Rafaella P. Lopes Magnago Teodiano B. Freire Filho Fernando Luiz H. Vieira Irani do Carmo F. Fin Sergio R. Eis Jones B. Graceli Leticia B.A. Rangel Ian V. Silva 《Journal of clinical densitometry》2018,21(2):227-235
Osteoporosis is one of the major diseases that affects mostly postmenopausal women. Despite being a multifactorial disease, some genes have been shown to play an important role in osteoporosis. Bone mineral density (BMD) is still largely used to diagnose it, although many other biomarkers are used to better follow the disease onset. It has been shown that the apolipoprotein E (APOE) gene could be a biomarker for risk of fractures as well as to predict lower BMD in patients with osteoporosis. The human APOE gene encodes 3 protein isoforms called ApoE2, ApoE3, and ApoE4, resulting in 4 possible genotypes, because they are a product of a single nucleotide polymorphism found in this gene. So far, the APOE4 allele has been associated with low BMD in postmenopausal women and to incidence of bone breaking in older women. This study aimed to investigate the role of ApoE isoforms in a cohort of 413 postmenopausal Brazilian women. These patients were randomly recruited, clinically examined, and subjected to dual-energy X-ray absorptiometry to measure their BMD. Patients were further grouped as normal BMD (T-score?<?0.5) or low BMD (T-score?>?1.0, osteopenic or osteoporotic). Patients with osteopenia or osteoporosis were further genotyped for APOE alleles as well as tested for many serum bone turnover biomarkers. Our data showed that presence of the APOE3 allele was associated with both higher BMDs and higher serum concentrations of osteocalcin and alkaline phosphatase, biomarkers for bone formation. On the other hand, the APOE2 and APOE4 alleles were associated with lower BMD as well as higher levels of serum C-terminus collagen peptide and urinary deoxipyridinolines, biomarkers for bone resorption. However, these effects on lower BMD and bone resorption biomarkers observed in either APOE2 or APOE4 alleles were eliminated when patients' genotype carried the APOE3 allele. Codominance of the APOE3 allele was also associated with lesser cases of bone fractures in these patients within a 5-year follow-up. In conclusion, our data show that APOE4 may be associated with lower bone formation as well as increased risk of osteoporosis and bone fractures, whereas APOE3 seems to decrease lowering BMD in postmenopausal women, and its presence seemed to lower the incidence of bone breaking in patients with osteoporosis. 相似文献
19.
Bone Mineral Density in French Canadian Women 总被引:3,自引:0,他引:3
C. Blanchet S. Dodin M. Dumont Y. Giguère L. Turcot-Lemay J. Beauchamp D. Prud'homme 《Osteoporosis international》1998,8(3):268-273
This cross-sectional study investigated bone mineral density (BMD) at the lumbar spine (L2–4) and femoral neck in French
Canadian women residing in the Quebec city area. Data collection was initiated in 1988 and completed in 1994. A total of 747
French Canadian Caucasian women (16–79 years of age) with no metabolic bone disease were evaluated. BMD measurements were
obtained using dual-photon absorptiometry (DPA) or dual-energy X-ray absorptiometry (DXA). Anthropometric measures such as
weight, height and body mass index (BMI) were recorded. Medical files provided information on demographic characteristics,
hormonal profile and lifestyle habits. Results show a curvilinear trend of BMD with aging. Furthermore, the peak BMD at the
lumbar spine (L2–4) was reached at 29 years followed by a stable phase until 35 years, after which BMD started to decrease.
The pattern of bone evolution at the femoral neck was different, peak BMD being achieved earlier, at 21 years, while after
age 26 years a significant decrease was already observed. Women older than 60 years showed the lowest BMD. Regression analysis
showed that age, weight and height are determinants of BMD at the lumbar spine and explained 33.9% of inter-individual variation.
At the femoral neck, 29.1% of variation was explained by age and height only. In conclusion, our data suggest that French
Canadian women have a different pattern of bone loss at the femoral neck compared with the lumbar spine, according to their
mean BMD values.
Received: 21 July 1997 / Accepted: 15 October 1997 相似文献
20.
C. A. C. Coupland M. J. Grainge S. J. Cliffe D. J. Hosking C. E. D. Chilvers 《Osteoporosis international》2000,11(4):310-315
Few studies have assessed the relationship between occupational activity and bone mineral density (BMD), although two case–control
studies have reported a protective effect of occupational activity on hip fracture. In the present study 580 postmenopausal
women aged 45–61 years completed a risk factor questionnaire including a detailed occupational history. For each job, hours
spent sitting, standing, walking, lifting and carrying were recorded; these measures, evaluated at ages 20, 30, 40 years,
in the current job and over the working lifetime, were used in the analysis. BMD was measured with dual-energy X-ray absorptiometry,
and measurements at five sites were used in a multiple regression analysis adjusting for potential confounding variables.
There was a significant negative association between sitting at age 20 years and BMD at the radius (p= 0.037), with negative relationships of borderline significance at the anteroposterior spine (p = 0.091) and whole body (p= 0.078). There were significant positive associations between standing at age 30 years and BMD at all five sites (p<0.05), but no significant linear associations for standing at ages 20 and 40 years. No significant associations were found
for lifetime or current occupational measures of sitting, standing, walking and lifting or carrying. The lack of consistency
of these significant findings suggests that they may have occurred by chance, and that occupational activity has little if
any effect on BMD in postmenopausal women.
Received: 12 March 1999 / Accepted: 17 September 1999 相似文献